Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 165 results.
User Information
Export Records
  1. 1.   NADPH oxidase 1 is highly expressed in human large and small bowel cancers
  2. Lu, Jiamo; Jiang, Guojian; Wu, Yongzhong; Antony, Smitha; Meitzler, Jennifer L; Juhasz, Agnes; Liu, Han; Roy, Krishnendu; Makhlouf, Hala; Chuaqui, Rodrigo; Butcher,Donna; Konaté, Mariam M; Doroshow, James H
  3. PloS one. 2020, May 19; 15(5): e0233208.
  1. 2.   Antineoplastic Agents. 548. Synthesis of lodo- and Diiodocombstatin Phosphate Prodrugs
  2. Pettit, G. R.; Rosenberg, H. J.; Dixon, R.; Knight, J. C.; Hamel, E.; Chapuis, J. C.; Pettit, R. K.; Hogan, F.; Sumner, B.; Ain, K. B.; Trickey-Platt, B.
  3. Journal of Natural Products. 2012, Mar; 75(3): 385-393.
  1. 3.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 4.   Plasma and CNS pharmacokinetics of O(4)-benzylfolic acid (O(4)BF) and metabolite in a non-human primate model
  2. Chuk, M. K.; Cole, D. E.; McCully, C.; Loktionova, N. A.; Pegg, A. E.; Parker, R. J.; Pauly, G.; Widemann, B. C.; Balis, F. M.; Fox, E.
  3. Cancer Chemotherapy and Pharmacology. 2011, Jun; 67(6): 1291-1297.
  1. 5.   Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
  2. Kang, Z. G.; Chen, J. J.; Yu, Y. K.; Li, B.; Sun, S. Y.; Zhang, B. L.; Cao, L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3181-3192.
  1. 6.   BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
  2. Crea, F.; Serrat, M. A. D.; Hurt, E. M.; Thomas, S. B.; Danesi, R.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Apr; 128(8): 1946-1954.
  1. 7.   The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy
  2. Xiang, X. R.; Phung, Y.; Feng, M. Q.; Nagashima, K.; Zhang, J. L.; Broaddus, V. C.; Hassan, R.; FitzGerald, D.; Ho, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 8.   Plant Natural Products in Anticancer Drug Discovery
  2. Grothaus, P. G.; Cragg, G. M.; Newman, D. J.
  3. Current Organic Chemistry. 2010, Oct; 14(16): 1781-1791.
  1. 9.   A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds
  2. Screpanti, E.; Santaguida, S.; Nguyen, T.; Silvestri, R.; Gussio, R.; Musacchio, A.; Hamel, E.; De Wulf, P.
  3. Plos One. 2010, Jul; 5(7): 13.
  1. 10.   The odyssey of marine pharmaceuticals: a current pipeline perspective
  2. Mayer, A. M. S.; Glaser, K. B.; Cuevas, C.; Jacobs, R. S.; Kem, W.; Little, R. D.; McIntosh, J. M.; Newman, D. J.; Potts, B. C.; Shuster, D. E.
  3. Trends in Pharmacological Sciences. 2010, Jun; 31(6): 255-265.
  1. 11.   Antitumor activity and COMPARE analysis of bis-indole derivatives
  2. Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Landi, L.; Prata, C.; Dalla Sega, F. V.; Caliceti, C.; Shoemaker, R. H.
  3. Bioorganic & Medicinal Chemistry. 2010, May; 18(9): 3004-3011.
  1. 12.   Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer
  2. Yan, X. D.; Yin, J.; Yao, H. Y.; Mao, N.; Yang, Y. L.; Pan, L. Y.
  3. Cancer Research. 2010, Feb; 70(4): 1616-1624.
  1. 13.   Peloruside B, A Potent Antitumor Macrolide from the New Zealand Marine Sponge Mycale hentscheli: Isolation, Structure, Total Synthesis, and Bioactivity
  2. Singh, A. J.; Xu, C. X.; Xu, X. M.; West, L. M.; Wilmes, A.; Chan, A.; Hamel, E.; Miller, J. H.; Northcote, P. T.; Ghosh, A. K.
  3. Journal of Organic Chemistry. 2010, Jan; 75(1): 2-10.
  1. 14.   Intracellular Activation and Deactivation of Tasidotin, an Analog of Dolastatin 15: Correlation with Cytotoxicity
  2. Bai, R.; Edler, M. C.; Bonate, P. L.; Copeland, T. D.; Pettit, G. R.; Luduena, R. F.; Hamel, E.
  3. Molecular Pharmacology. 2009 75(1): 218-226.
  1. 15.   Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
  2. Cao, X. F.; Plasencia, C.; Kanzaki, A.; Yang, A.; Burke, T. R.; Neamati, N.
  3. Current Cancer Drug Targets. 2009 9(2): 189-201.
  1. 16.   Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples
  2. Erickson, H. S.; Albert, P. S.; Gillespie, J. W.; Rodriguez-Canales, J.; Linehan, W. M.; Pinto, P. A.; Chuaqui, R. F.; Emmert-Buck, M. R.
  3. Nature Protocols. 2009 4(6): 902-922.
  1. 17.   Modulation of Carcinogen Metabolism by Nitric Oxide-Aspirin 2 Is Associated with Suppression of DNA Damage and DNA Adduct Formation
  2. MacDonald, C. J.; Cheng, R.; Roberts, D. D.; Wink, D. A.; Yeh, G. C.
  3. Journal of Biological Chemistry. 2009 284(33): 22099-22107.
  1. 18.   Connecting chemosensitivity, gene expression and disease
  2. Covell, D. G.
  3. Trends in Pharmacological Sciences. 2008 29(1): 1-5.
  1. 19.   Cytokeratin-RNA cross-linking mediated by the antitumor aminoflavone, 5-amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
  2. Meng, L. H.; Meng, Z. J.; Miao, Z. H.; Veenstra, T. D.; Pommier, Y.
  3. Journal of Pharmacology and Experimental Therapeutics. 2008 325(2): 674-680.
  1. 20.   Epitopes required for antibody-dependent enhancement of Ebola virus infection
  2. Takada, A.; Ebihara, H.; Feldmann, H.; Geisbert, T. W.; Kawaoka, Y.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S347-S356.
  1. 21.   Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples
  2. Erickson, H. S.; Albert, P. S.; Gillespie, J. W.; Wallis, B. S.; Rodriguez-Canales, J.; Linehan, W. M.; Gonzalez, S.; Velasco, A.; Chuaqui, R. F.; Emmert-Buck, M. R.
  3. Laboratory Investigation. 2007, Sep; 87(9): 951-962.
  1. 22.   cis sequence effects on gene expression
  2. Bergen, A. W.; Baccarelli, A.; McDaniel, T. K.; Kuhn, K.; Pfeiffer, R.; Kakol, J.; Bender, P.; Jacobs, K.; Packer, B.; Chanock, S. J.; Yeager, M.
  3. Bmc Genomics. 2007, Aug; 8
  1. 23.   Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data
  2. Covell, D. G.; Huang, R. L.; Wallqvist, A.
  3. Molecular Cancer Therapeutics. 2007, Aug; 6(8): 2261-2270.
  1. 24.   A mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type IIFN-induced apoptosis
  2. Scarzello, A. J.; Romero-Weaver, A. L.; Maher, S. G.; Veenstra, T. D.; Zhou, M.; Qin, A.; Donnelly, R. P.; Sheikh, F.; Gamero, A. M.
  3. Molecular Biology of the Cell. 2007, Jul; 18(7): 2455-2462.
  1. 25.   Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions
  2. Wang, D. W.; Jao, L. E.; Zheng, N. Z.; Dolan, K.; Ivey, J.; Zonles, S.; Wu, X. L.; Wu, K. M.; Yang, H. B.; Meng, Q. C.; Zhu, Z. Y.; Zhang, B.; Lin, S.; Burgess, S. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jul; 104(30): 12428-12433.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel